UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Your gut harbors trillions of microbes which live in precarious harmony with your immune system. When that harmony is upset, ...

A subgroup analysis of patients with moderately to severely active Crohn’s disease showed greater clinical and endoscopic ...

TORONTO, Nov. 4, 2025 /CNW/ – This November, in honour of Crohn’s and Colitis Awareness Month, Crohn’s and Colitis Canada is spotlighting the courage and resilience of children and youth living ...

Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...

For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall costs than beginning with conventional treatments and escalating later.

UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be ...

With an increasing number of available drugs along with a focus on early treatment regimens and drug sequencing in Crohn's disease, data from prospective, well designed studies to guide on drug choice ...

With about 190,000 people in the UK living with the disease and 10,000 diagnosed annually, the early treatment method could ...

UC San Diego researchers have resolved a decades-long debate about the role of the first Crohn’s disease gene linked to an increased risk of developing the autoimmune condition. The human digestive ...